The molecular basis of RECQ4-associated genetic disorders and cancer predispositi

RECQ4相关遗传性疾病和癌症易感性的分子基础

基本信息

  • 批准号:
    8101561
  • 负责人:
  • 金额:
    $ 8.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-03-01 至 2011-09-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Functional machineries to prevent and repair DNA damages are required for maintaining genome integrity and preventing tumourigenesis. A set of proteins belonging to the RecQ family is among the cancer suppressors linked to repairing lesions caused by DNA damaging agents, such as ionizing radiation and cisplatin. During the course of evolution, RecQ genes appear to have been amplified and diverged from a single copy of the RecQ gene in bacteria and yeast to five RecQ homologs in humans. The clinical phenotypes caused by mutations in different RECQ proteins in humans and mouse models indicate that they have important and non-overlapping roles in maintaining genomic integrity and cancer prevention. Since RECQ helicases are highly interactive proteins and form large protein complexes in vivo, the unique functions of each of the RECQ proteins are likely defined and regulated by the specific protein-protein interactions they form in cells. To understand how the mammalian RECQ proteins act as tumor suppressors and caretakers for our genome, it is crucial to understand the unique functions of each of the RECQ protein complexes. Recently, our lab has several breakthroughs in the study of human RECQ4 helicase. First, we successfully reported ATP-dependent RECQ4 helicase activity in vitro. Surprisingly, domain analyses uncovered two distinct ATP binding and DNA unwinding activities within the RECQ4 protein. Secondly, we report the identification of a highly purified chromatin bound RECQ4 complex from human cell extracts. We found that essential replisome factors MCM10, MCM2-7 helicase, CDC45 and GINS are the primary interaction partner proteins of human RECQ4. Moreover, circadian proteins, TIMELESS and TIPIN important for cohesion establishment and DNA replication progression are part of the RECQ4 complex. Importantly, complex formation and the association of RECQ4 with the replication origin are cell cycle regulated. Our studies allow us to conclude that RECQ4 is an integral component of the MCM replicative helicase complex participating in DNA replication in human cells. Based on our work, the goal of this proposal is to define the exact function of RECQ4 complex in DNA replication, cohesion establishment and cancer avoidance. The Specific Aims are: (1) dissecting the role of human RECQ4 in DNA replication initiation; (2) Establishing the functional relationship between RECQ4 and TIM-TIPIN heterodimer in replication fork progression, genotoxic stress response and cohesion establishment; and (3) Analysis of the cancer-associated RECQ4 (c.1390+2delT) mutation. PUBLIC HEALTH RELEVANCE: DNA replication is essential for cell growth, and abnormal DNA synthesis can result in genome instability, mutagenesis and tumorigenesis. Therefore, elucidation of the mechanisms that regulate DNA replication and the molecular functions of the involved proteins, such as RECQ4, are fundamental to our understanding of the cancer development. Crucially, our detailed knowledge on the DNA replication factors will aid in the discovery of new cancer therapy treatments, since inhibiting DNA replication factors effectively prevents cell proliferation.
描述(由申请人提供):防止和修复DNA损伤的功能机器是维持基因组完整性和防止肿瘤发生所必需的。一组属于RecQ家族的蛋白质是与修复DNA损伤剂(如电离辐射和顺铂)造成的损伤有关的癌症抑制因子之一。在进化过程中,RecQ基因似乎已经被扩增,并从细菌和酵母中的RecQ基因的一个副本分化为人类的五个RecQ同源物。在人类和小鼠模型中,不同的RecQ蛋白突变引起的临床表型表明,它们在维持基因组完整性和癌症预防方面具有重要且不重叠的作用。由于RecQ解旋酶是高度相互作用的蛋白质,并在体内形成大型蛋白质复合体,因此每个RecQ蛋白质的独特功能可能由它们在细胞中形成的特定蛋白质-蛋白质相互作用来定义和调节。要了解哺乳动物的RecQ蛋白如何作为我们基因组的肿瘤抑制者和看守者,了解每个RecQ蛋白复合体的独特功能是至关重要的。最近,我们实验室在人类RECQ4解旋酶的研究上取得了几项突破。首先,我们成功地报道了依赖于ATP的RECQ4解旋酶的体外活性。令人惊讶的是,结构域分析发现RECQ4蛋白中有两种不同的ATP结合和DNA解离活性。其次,我们报道了从人类细胞提取物中鉴定出一个高纯度的染色质结合RECQ4复合体。我们发现基本复制体因子MCM10、MCM2-7解旋酶、CDC45和GINS是人RECQ4的主要相互作用伙伴蛋白。此外,昼夜节律蛋白质是RECQ4复合体的一部分,它们对凝聚力的建立和DNA复制进程至关重要,是永恒的和关键的。重要的是,复合体的形成和RECQ4与复制起点的关联是细胞周期调节的。我们的研究使我们得出结论,RECQ4是参与人类细胞DNA复制的MCM复制型解旋酶复合体的组成部分。基于我们的工作,这项建议的目标是确定RECQ4复合体在DNA复制、凝聚力建立和癌症预防中的确切功能。其具体目的是:(1)剖析人类RECQ4在DNA复制启动中的作用;(2)建立RECQ4和Tim-tipin异二聚体在复制分叉进展、遗传毒性应激反应和凝聚力建立中的功能关系;以及(3)分析与癌症相关的RECQ4(c.1390+2delT)突变。 与公共卫生相关:DNA复制对细胞生长至关重要,DNA合成异常可能导致基因组不稳定、突变和肿瘤形成。因此,阐明调控DNA复制的机制和相关蛋白的分子功能,如RECQ4,对于我们理解癌症的发展是至关重要的。至关重要的是,我们对DNA复制因子的详细了解将有助于发现新的癌症治疗方法,因为抑制DNA复制因子有效地阻止了细胞增殖。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yilun Liu其他文献

Yilun Liu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yilun Liu', 18)}}的其他基金

RECQ5-dependent SUMO2 conjugation of PCNA in the resolution of transcription-replication conflicts
PCNA 的 RECQ5 依赖性 SUMO2 缀合解决转录复制冲突
  • 批准号:
    10328909
  • 财政年份:
    2019
  • 资助金额:
    $ 8.4万
  • 项目类别:
RECQ5-dependent SUMO2 conjugation of PCNA in the resolution of transcription-replication conflicts
PCNA 的 RECQ5 依赖性 SUMO2 缀合解决转录复制冲突
  • 批准号:
    10558750
  • 财政年份:
    2019
  • 资助金额:
    $ 8.4万
  • 项目类别:
The function of Topoisomerase I SUMOylation in transcription and chemoresistance
拓扑异构酶 I SUMO 化在转录和化疗耐药中的作用
  • 批准号:
    9901592
  • 财政年份:
    2018
  • 资助金额:
    $ 8.4万
  • 项目类别:
The function of Topoisomerase I SUMOylation in transcription and chemoresistance
拓扑异构酶 I SUMO 化在转录和化疗耐药中的作用
  • 批准号:
    10132345
  • 财政年份:
    2018
  • 资助金额:
    $ 8.4万
  • 项目类别:
The molecular basis of RECQ4-associated genetic disorders and cancer predispositi
RECQ4相关遗传性疾病和癌症易感性的分子基础
  • 批准号:
    8371475
  • 财政年份:
    2011
  • 资助金额:
    $ 8.4万
  • 项目类别:
The molecular basis of RECQ4-associated genetic disorders and cancer predispositi
RECQ4相关遗传性疾病和癌症易感性的分子基础
  • 批准号:
    8228028
  • 财政年份:
    2011
  • 资助金额:
    $ 8.4万
  • 项目类别:
The molecular basis of RECQ4-associated genetic disorders and cancer predispositi
RECQ4相关遗传性疾病和癌症易感性的分子基础
  • 批准号:
    8811101
  • 财政年份:
    2011
  • 资助金额:
    $ 8.4万
  • 项目类别:
The molecular basis of RECQ4-associated genetic disorders and cancer predispositi
RECQ4相关遗传性疾病和癌症易感性的分子基础
  • 批准号:
    8444281
  • 财政年份:
    2011
  • 资助金额:
    $ 8.4万
  • 项目类别:
The molecular basis of RECQ4-associated genetic disorders and cancer predispositi
RECQ4相关遗传性疾病和癌症易感性的分子基础
  • 批准号:
    8623102
  • 财政年份:
    2011
  • 资助金额:
    $ 8.4万
  • 项目类别:
Ionizing Radiation-Induced DNA damage repair
电离辐射诱导的 DNA 损伤修复
  • 批准号:
    10475652
  • 财政年份:
    2009
  • 资助金额:
    $ 8.4万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 8.4万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 8.4万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 8.4万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 8.4万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 8.4万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 8.4万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 8.4万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 8.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 8.4万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 8.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了